P-piller

Siden det er snakk om naturlig prevensjon vs p-piller nå, legger jeg ved et gammelt dokument om helsefarer ved bruk av p-piller. Dokumentet er ikke oppdatert på mange år, så de fleste linkene er nok døde. Men, det er tilstrekkelig med forskningsreferanser i dokumentet til å gi en ide om hvor helsefarlig p-piller faktisk er.

PirkePetter














4 Ways to Repair the Hormone Imbalance from The Pill -


http://empoweredsustenance.com/the-pill-hormone-damage/






Overgangsalder: den uhyggelige hormonbommert –


http://www.helsenyt.com/frame.cfm/cms/id=2879/sprog=1/grp=9/menu=3/






Hormonrisiko kendt i mange år –


http://www.helsenyt.com/frame.cfm?id=3271&sprog=1&grp=9&menu=3






Hormoner øger risiko for brystkræft og blodpropper –


http://www.helsenyt.com/frame.cfm?id=3127&sprog=1&grp=9&menu=3






POSTMENOPAUSAL ESTROGEN USE/LUPUS
Women who use estrogen are at increased risk of developing systemic lupus erythematosus. The risk increases as length of time the estrogen is used increases. The risk drops as estrogen use is discontinued. (Medical Tribune 35(22)8, November 17, 1994)






ESTROGEN REPLACEMENT THERAPY/SYSTEMIC LUPUS ERYTHEMATOSUS
Women who are taking postmenopausal hormone replacement therapy are at increased risk of developing systemic lupus erythematosus. The risk increases as the length of time the hormones are taken increases. (Arthritis and Rheumatism 37(Suppl 9)S211, September 1994)






ESTROGEN REPLACEMENT THERAPY/OVARIAN CANCER
Women who use long-term estrogen replacement therapy are at increased risk of developing fatal ovarian cancer according to a study from Emory University and the American Cancer Society. (American Journal of Epidemiology 141(9)828-35, 1995)






BREAST CANCER FROM HORMONE USE


More than 5 years of use of estrogen with progestin increases the risk of breast cancer by 9% per year. Reference: Am J Epidemiol. 147(suppl):645. 1998






ESTROGENS/FIBROCYSTIC BREAST DISEASE
Two different studies have revealed that estrogen use increases rates of fibrocystic breast disease. A Massachusetts study reveals increased rates of hospitalization for fibrocystic breast disease during the first year of estrogen use, then during the fourth, fifth and following years. As years of use increase so does risk. None of the previously known risk factors for fibrocystic breast disease (late age at menopause, no or few pregnancies, age, race, and socioeconomic status) appear to influence fibrocystic breast disease rates as markedly as does estrogen use. (American Journal of Epidemiology 121:238-245, 1985; American Journal of Epidemiology 124(5)746-751, 1986






ESTROGEN/GALLBLADDER DISEASE
Women who take estrogen are at increased risk of developing gallbladder disease requiring gallbladder removal. A new study demonstrates that the elevated risk remains even after the use of estrogen is discontinued. (Gastroenterology 94:91-95, 1988)






Synthetic Hormone Replacement Therapy Can Cause Strokes –


http://www.mercola.com/2005/jan/26/hrt_strokes.htm






Hormone Replacement Therapy –


http://www.findarticles.com/cf_0/m0HKL/5_7/66918299/p1/article.jhtml?term=%2BLow-protein+%2Bdiet+%2BPhysiological+%2Baspects






Unreliable study hid dangers of HRT –


http://www.timesonline.co.uk/article/0,,8122-1017726,00.html


http://www.hghnews.us/p/167,642.html






Health Facts: Caveats - HRT and Men's HRT –


http://www.jrussellshealth.com/caveatshrt.html






The Medicalization of Menopause –


http://www.oxford.net/~tishy/thesis1sec1.html






Menopause, HRT and other Myths –


http://www.holistichealthtools.com/meno.html






Mythologies of Menopause in Japan and North America - http://texts.cdlib.org/xtf/search?&subject="Medical Anthropology"&profile=kt3v19p5bk kt5z09p6zn&profile-join=or&rmode=eschol&startDoc=1#ft3v19n940






Östrogen bakom 3 400 cancerfall
http://www.svd.se/dynamiskt/inrikes/did_9585630.asp
Nästan vart femte fall av bröstcancer hos medelålders svenska kvinnor under 1990-talet kan kopplas till hormonbehandling under klimakteriet. Oftast handlar det om östrogen i kombination med gulkroppshormon. Av totalt 18 916 fall av bröstcancer bland 50-64-åriga kvinnor uppskattas 3 440 ha denna förklaring






Ny studie om hormonbehandling av klimakteriebesvär och risk för återfall i bröstcancer
http://info.ki.se/article_se.html?ID=3379
Enligt en färsk studie från Karolinska Institutet, som publiceras den 6 april i tidskriften Journal of the National Cancer Institut, kan det finnas ett samband mellan de doser av gulkroppshormon som används tillsammans med östrogen vid hormonbehandling av klimakteriebesvär och risken för återfall i bröstcancer.

År 1997 påbörjades två randomiserade studier i Sverige, HABITS-studien (Hormonal Replacement Therapy—Is It Safe?) och Stockholmstudien. I båda studierna undersöks effekterna av hormonbehandling av klimakteriebesvär hos kvinnor som hade fått diagnosen bröstcancer i ett tidigt stadium.

HABITS-studien, som i slutändan omfattade 345 bröstcancerpatienter, avbröts i förtid i december 2003, när forskarna vid en medianuppföljning på endast 2,1 år fann att risken för återfall i bröstcancer hos kvinnor som fick hormonbehandling var 3,3 gånger högre än risken bland de kvinnor som inte fick någon behandling






Kombinerad hormonbehandling medför högre risk för bröstcancer än singelhormonterapihttp://www.nymedicin.com/news/2000/01/27/Kombinerad_hormonbehandling_medfor_hogre_risk_for.html
Catherine Schairer och kollegor vid National Cancer Institute har funnit att kvinnor med pågående hormonbehandling för menopausala besvär har högre risk för att få bröstcancer än kvinnor som endast tar östrogen....






Estrogen, Heart Disease And Cancer


For years estrogen and estrogen synthetic progesterone hormones have been prescribed to postmenopausal women for the relief of menopausal symptoms. An added benefit was that it was believed that this estrogen replacement therapy helped protect women against cardiovascular disease.


New research has shown that there is in fact no change in cardiovascular risk for women who are taking estrogen replacement hormones compared to those who do not.


On the other hand, the risk of breast cancer has been demonstrated to be significantly increased after only one year of estrogen use. Researchers evaluated some 51 different epidemiological studies of some 160,000 women to prove the correlation between estrogen and breast cancer.


A better alternative for women is natural progesterone therapy which has none of the side effects of the estrogens. (See previous issues of the Health Letter for recommendations on the use of natural progesterones.)


Progesterones are also the treatment of choice for endometriosis. This can be a difficult disease to treat and the use of pharmaceuticals such as Lupron can make women extremely sick. Additionally, some practitioners recommend that their patients get pregnant in order to cure the condition, since pregnancy results in a dramatic increase in progesterone levels. For those who don’t really want to have a baby as a method of treating a disease, natural progesterone therapy would certainly be a good alternative.


Reference: Ann Intern Med 1997;127:501-508, Lancet, October 11, 1997:1041-44, 1047-59, Fertil Steril, September 1997:393-401 - Dr. R. L. Wysong, July 1998






HORMONE HERESY –


http://www.nexusmagazine.com/articles/hormone1.html


http://www.nexusmagazine.com/articles/hormone2.html






Estrogens: Premarin lowers folic-acid and B6 levels, which can raise blood homocysteine levels (elevated homocysteine is a major risk factor for heart disease and stroke. Research has not found which nutrients are depleted by estrogens but one would assume it would be similar to those of birth control pills - lower levels of vitamins B1, B2, B4, B6 and C and the minerals zinc and manganese. These contraceptives also decrease blood levels of amino acids and increase levels of cholesterol and triglycerides - both risk factors for heart disease. Estrogens also raise glucose levels, which may predispose a woman to insulin resistance and diabetes, which further increase the risk of heart disease. Estrogens boost sodium levels and increase fluid retention.




OOPS, WE WERE WRONG


For years the pharmaceutical industry has promoted hormone replacement therapy (HRT), involving the use of estrogen extracted from pregnant mares' urine, as a panacea for women experiencing difficulties in menopause, and as a protection against heart disease, bone loss and even Alzheimer's. The enormously successful campaign to get every menopausal woman on drugs began in 1966 when Wyeth-Ayerst, developer of the drug, paid Robert Wilson, an enthusiastic doctor, to write a bestselling book called Feminine Forever and then financed him to fly around the country promoting it. Wilson told women and doctors alike that estrogen therapy "could keep women young, healthy and attractive." He painted a dire picture of the consequences to women who resisted. "At age 50, there are no ova, no follicles, no thesa, no estrogen—truly a galloping catastrophe." Wilson promised that estrogen therapy could save women from the ravages of age. "Breasts and genital organs will not shrivel. Such women will be much more pleasant to live with and will not become dull and unattractive." This offensive propaganda spurred billions of dollars in sales of HRT drugs yearly. Now a rigorous study has found that HRT causes increases in breast cancer, heart attacks, strokes and blood clots. The study did not even show that HRT could reduce the risk of bone fractures. Other trials have demolished the theory that HRT protects against Alzheimer's. Sixteen thousand participants in the study, the Women's Health Initiative sponsored by the National Institutes of Health, received notices to discontinue HRT and Wyeth stock fell 24 percent after the report (New York Times 8/10/2002). The lesson: be skeptical of claims for patented medicines. But it's a lesson that Americans are taking a long time to learn.


http://www.westonaprice.org/caustic_comments/fall2002.html






Scientists suspect hormone replacement therapy and the growing epidemic of obesity are behind a "surprising" 2% increase each year in the number of large breast cancer tumors found in newly diagnosed women in the U.S. since 1990 –


http://www.eces.org/articles/000431.php






ESTROGEN REPLACEMENT
Jacques Rossouw, M.D., from the National Institutes of Health Women's Health Initiative told the National Cancer Institute's advisory board that physicians are "rushing to judgement" regarding the use of estrogen. He points out that as baby boomers age more, more of them are being given estrogen replacement replacements, but it has not yet been proven that they actually are effective in preventing osteoporosis or heart disease. The FDA has approved the use of estrogen only for the treatment of menopausal symptoms and diagnosed osteoporosis; not for the prevention of these diseases.
Estrogen supplements increase the risk of breast cancer. (Journal of the National Cancer Institute 88(10)637-638, May 15, 1996)






ESTROGEN REPLACEMENT THERAPY/FATAL OVARIAN CANCER
The long-term use of estrogen replacement therapy may increase the risk of developing fatal ovarian cancer according to a recent study from the American Cancer Society and the Emory University School of Public Health. Risk increases as duration of use increases.
Previous studies on the relationship between estrogen use and ovarian cancer did not study duration of use.
The authors of this study point out that the women in this study group were given higher doses of estrogen than are given today.
Another interesting finding in this study was that menarche after 12 years of age is associated with a reduced risk of later ovarian cancer. (American Journal of Epidemiology 141(9)828-35, 1995)






Three New Studies About HRT -
A recent study published in The Lancet found that out of one million British women, 22% taking hormone replacement therapy had a higher risk of dying from breast cancer than those who had never taken the drugs. The risk wore off within a few years of stopping the treatments.
The Lancet 8/8/2003






Estrogen Replacement Can Be Healthy or Dangerous –


http://www.mercola.com/2004/oct/23/estrogen_replacement.htm


http://articles.mercola.com/sites/articles/archive/2010/05/04/the-estrogen-dilemma.aspx







Two new studies published in the New England Journal of Medicine found that hormone replacement therapy did not protect women from heart disease, as once believed. One of the studies found that it may actually increase the incidence of heart attack (by 81% in the first year of the taking the hormones). The other study found that arteries clogged just as rapidly in women taking hormones as in women taking the placeboNew England Journal Medicine 8/6/2003 - http://www.nutritionalconcepts.com/Health%20News%20Tidbits/Health%20News%20September%202003.htm






Synthetic Estrogen Pills Cause Urinary Incontinence in Over Half of Women –


http://www.dreddyclinic.com/findinformation/uu/urinary_incontinence/urinaryincontinence_3.php


http://www.mercola.com/2005/mar/12/estrogen_pills.htm






Two new studies link hormone replacement therapy (HRT) to an increased risk of developing asthma and hearing loss –


http://www.eces.org/articles/000809.php










***************************************************************************


***************************************************************************


***************************************************************************










BIRTH CONTROL PILLS/BIRTH DEFECTS
Use of oral contraceptives has been associated with an increased risk of leg or arm defects in infants. Infants with abnormalities were more likely to have been conceived while the mother was taking birth control pills. (American Journal of Obstetrics and Gynecology 155:1072-8, 1986)




DRUGS FOR THE "MORNING AFTER" CONTRACEPTIVE


Diethystilbestrol (see above – “DRUGS TO PREVENT MISCARRIAGE”) prescribed to prevent miscarriage (which it causes), was also doled out to whole populations as a morning-after pill though the dangers were known. Causes still-birth, infertility, congenital defects, malformations, breast cancer, asthma, arthritis, diabetes. Worldwide thousands of legal claims made against Eli Lilly and other pharmaceutical companies. A Dutch DES Report estimates that in the European community alone up to 9 million people could have been exposed to DES in the womb. That ninety percent of women prescribed DES now have problems in their reproductive organs. –


http://www.health.org.nz/drug3.html


http://www.health.org.nz/chapter21.html






Health Facts: Caveats - DES and Thalidomide –


http://www.jrussellshealth.com/caveatsdes.html






Higher STDs Tied to Popular Contraceptive –


http://s3.amazonaws.com/storage.nm-storage.com/truelifewellness/downloads/Higher_STDs_Tied_to_Popular_Contraceptive.doc


http://www.mercola.com/2004/sep/11/depo_provera_std.htm






IT WAS APPROVED


About 25 years ago it became apparent that the drug diethylstilbestrol (DES) was causing vaginal cancer in daughters born of women who were treated with the hormone during pregnancy. Over 6 million pregnant American women were given this drug to prevent miscarriages even though it was later found to be ineffective for this purpose.


Adding to this horror story it is now found that the children of DES mothers can be infertile, can actually have an increased incidence of miscarriage, and boys can have cystic testicles, testicular cancer and a tiny penis. Added to this, the hormone is believed to cause damage to the immune system increasing the susceptibility to autoimmune disorders such as thyroiditis, pernicious anemia, myasthenia gravis, Crohn’s disease, chronic fatigue syndrome, multiple sclerosis and breast and prostate cancer. Even the granddaughters of DES treated mothers are at increased risk of disease. DES children would now be in the 20-to 30-year old range. These should investigate whether their mothers took the drug if they have any of the above symptoms.


But this is only one of many FDA/doctor approved pharmaceutical disasters. A drug, practically by definition, is dangerous.






CROHN'S DISEASE/ORAL CONTRACEPTIVES
Crohn's disease limited to the colon has been shown to be more frequent in women who had taken oral contraceptives in the year prior to the development of symptoms according to a British study. Previous reports have suggested a relationship between oral contraceptives and colitis, and this study supports those reports. Women who developed colitis improved after discontinuation of the medication. (British Medical Journal 288:595-596, February 25, 1984) No hormone is without some hazard.






BIRTH CONTROL PILLS/CROHN'S DISEASE
Several recent studies have suggested a high risk of inflammatory disease in women who use oral contraceptives. One study revealed a twofold greater incidence of Crohn's disease in oral contraceptive users than in nonusers; another study revealed a 40 percent larger incidence in oral contractive users. Risk decreases after oral contraceptives are stopped, disappearing after about four years. The longer the oral contraceptives are used, the greater the risk. (Gastroenterology 89:1046-1049, 1985)




ORAL CONTRACEPTIVES


Found to increase the risk of blood-clots leading to heart attacks, lung disorders and strokes. By 1980 over 400 deaths reported.


"Not only had the animal tests failed to identify the hazard, but in rats and dogs oral contraceptives produced entirely the opposite effect, making it more difficult for the blood to clot."
(Z. Bankowski and N. Howard-Jones, Biomedical Research Involving Animals.)






[Liver lesions caused by oral contraceptives. I. Contraceptive-induced hepatosis in 85 women: recommendations for diagnosis and prophylaxis] –


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=668503&dopt=Abstract




HIGH ESTROGEN CONTRACEPTIVE PILL


Seventeen deaths between January 1 and end March 1982. Medical Journal Annual Reports claim 787 deaths.


"This is less than usual probably owing to drop in reporting by doctors rather than improvements in drug safety."
(Committee for the Safety of Medicines.) –


http://www.health.org.nz/drug3.html


http://www.health.org.nz/chapter21.html






How Contraceptives Kill a Woman's Libido Long-Term –


http://www.mercola.com/2005/jun/14/contraceptives_libido.htm






Birth Control Pill Side Effects –


http://www.jeffreywarber.com/hc%20pages/pillsideeffects.html






Birth Control Pill Linked to Two Types of Cancer - http://www.mercola.com/2005/aug/20/birth_control_pill_linked_to_two_types_of_cancer.htm






ORAL CONTRACEPTIVES/MYOCARDIAL INFARCTION
The use of oral contraceptives (OCs) almost doubles the risk of myocardial infarction in women. Those who smoke and have high blood pressure exhibit a dramatic increase in risk with the use of OCs. The total study population demonstrated a 1.8 risk rate, while non-smokers without other risk factors had a 2.8 fold increase in risk. Smokers who used OCs showed a 5.6-fold greater risk than those with no risk factors. (Family Practice News 10(20)24, October 15, 1980)






ESTROGEN Fails the Heart Test –


http://www.lef.org/isyndicate/articles/isynd-june99-report1.html






Estrogen Can Also Increase Risk of Ovarian Cancer –


http://www.dcnutrition.com/news/Detail.CFM?RecordNumber=485


http://www.mercola.com/2001/apr/4/estrogen.htm






Farlige P-piller/Hormontilskud til kvinder er farlige –


http://www.helsenyt.com/frame.cfm/cms/id=1463/sprog=1/grp=9/menu=3/


http://www.helsenyt.com/frame.cfm?id=2810&sprog=1&grp=9&menu=3






P-piller fordobler risikoen for livmoderhalskræft/P-piller giver blodpropper –


http://www.helsenyt.com/frame.cfm/cms/id=2653/sprog=1/grp=9/menu=3/


http://www.helsenyt.com/frame.cfm?id=2029&sprog=1&grp=9&menu=3






CARCINOGENS: The reproductive hormone estrogen, a component of hormone replacement therapy, has joined the government's roster of known causes of cancer in humans. Estrogen is known to cause breast and uterine tumors. (National Toxicology Program, 10th Report on Carcinogens, 2002.) –


http://www.wysong.net/health/post_99_123002.shtml






CERVICAL ADENOCARCINOMA RISK FACTORS
The incidence of cervical adenocarcinoma in women under 35 years-of-age has more than doubled since the 1970s. Los Angeles researchers studied nearly 600 women in an attempt to understand the factors which contribute to this disease. They report that the number of sexual partners before the age of 20, weight gain, and long-term use of oral contraceptives increase the risk. Women of low educational attainment and lower economic status also appear to be at increased risk. (Cancer Causes and Control 7:391-401, 1996)






Hormonrisiko kendt i mange år –


http://www.helsenyt.com/frame.cfm?id=3271&sprog=1&grp=9&menu=3






BIRTH CONTROL/FIBROCYSTIC DISEASE OF THE BREAST
Women who have previously used oral contraceptives are more likely to develop fibrocystic disease of the breast after menopause. (American Journal of Epidemiology 120:87-96, 1984)






ESTROGENS/FIBROCYSTIC BREAST DISEASE
Two different studies have revealed that estrogen use increases rates of fibrocystic breast disease. A Massachusetts study reveals increased rates of hospitalization for fibrocystic breast disease during the first year of estrogen use, then during the fourth, fifth and following years. As years of use increase so does risk. None of the previously known risk factors for fibrocystic breast disease (late age at menopause, no or few pregnancies, age, race, and socioeconomic status) appear to influence fibrocystic breast disease rates as markedly as does estrogen use. (American Journal of Epidemiology 121:238-245, 1985; American Journal of Epidemiology 124(5)746-751, 1986






ORAL CONTRACEPTIVES/FIBROCYSTIC BREAST DISEASE
Some studies have suggested that birth control pills may reduce the risk of fibrocystic breast disease. It now appears that this holds true only for a specific type of fibrocystic disease-- the type least likely to progress to breast cancer. A new study now reveals that women who have never used birth control pills are at a lower risk of fibrocystic disease as a whole. (Journal of the National Cancer Institute 71:5-9, 1983)






ORAL CONTRACEPTIVES/BREAST CANCER
Birth control pills may stimulate breast cancer, particularly in older users, according to a California study. It is felt that latent cancer cells present in the breast may be stimulated into active growth. (Cancer 59:281-287, 1987)






BIRTH CONTROL PILLS/CERVICAL CANCER
There has been a marked increase in the incidence of cancer of the cervix in the under-35 age group. There is some suggestion that this increase may be due to changes in the cervix which are associated with the use of birth control pills. (British Medical Journal 295:1446-1447, December 5, 1987






ESTROGEN REPLACEMENT THERAPY/OVARIAN CANCER
Women who use long-term estrogen replacement therapy are at increased risk of developing fatal ovarian cancer according to a study from Emory University and the American Cancer Society. (American Journal of Epidemiology 141(9)828-35, 1995)






ORAL CONTRACEPTIVES - Do The Risks Out-Weigh The Benefits?


http://www.afpafitness.com/oralcont.htm






The Real Dangers of The Pill –


http://www.thedoctorwithin.com/women/every-woman-needs-to-read-this-chapter-now/






Is Estrogen Carninogenic –


http://www.smart-publications.com/articles/di-indolylmethane-02.html






BREAST CANCER FROM HORMONE USE


More than 5 years of use of estrogen with progestin increases the risk of breast cancer by 9% per year. Reference: Am J Epidemiol. 147(suppl):645. 1998






Warning Over New Contraceptive Pill Risk –


http://www.nzherald.co.nz/storydisplay.cfm?storyID=1290887&thesection=news&thesubsection=general&reportID=16






Birth Control Pills Linked to Thinner Bones –


http://mercola.com/2001/nov/24/birth_control.htm






Using Provera Leads to Early Bone Loss –


http://www.mercola.com/2005/jan/8/celebrex_heart.htm






Birth Control Pill Increases Risk of Fatal Embolism –


http://mercola.com/2000/jun/24/birth_control_pills.htm






Birth Control Pills Increase Blood Clot Risk –


http://mercola.com/2000/dec/3/birth_control_pills.htm






Newest Version Of The Pill May Cause Blood Clots - http://mercola.com/1999/archive/newest_version_of_the_pill_may_cause_blood_clots.htm






Pill, Gene Defect Tied to Clot Risk –


http://mercola.com/1998/archive/gene_defect.htm






Oral Contraceptives, Low HDL Increase Stroke Risk –


http://mercola.com/2000/jul/2/pill_hdl_stroke.htm






More Problems for Contraceptives and Hormone Replacement Therapy –


http://mercola.com/2004/jun/26/contraceptives_hrt.htm






Abnormal Hormonal Levels Linked to MS –


http://www.mercola.com/2004/feb/14/vitamin_d_ms.htm






Just Say No to Birth Control Pills –


http://www.mercola.com/2004/oct/27/birth_control.htm






Major Warnings on Injectable Birth Control –


http://www.mercola.com/2004/dec/4/birth_control.htm






False Promises, Ignorance and Fast-Paced Medicine: A Doctor Speaks Out Against Lupron –


http://mercola.com/2002/mar/9/lupron.htm






Bedre Medicin –


http://bedremedicin.dk/






Piller: "Nyt" er ikke nødvendigvis "bedre" –


http://www.natur-drogeriet.dk/frame.cfm/cms/id=3174/sprog=1/grp=4/menu=3/






Koffeininntaket øker med hele 50 prosent når man samtidig bruker p-piller –


http://www.helsenytt.no/artikler/kaffe.htm






GLUCOSE TOLERANCE/ORAL CONTRACEPTIVES
Women 20 to 44 years of age who are taking birth control pills have been shown to have impaired glucose tolerance (higher blood sugar levels) compared to women not on birth control pills. (Journal of Chronic Disease 40(1)3-11, 1987) Abnormal blood glucose levels may be predictive of both diabetes mellitus and heart disease






DEAFNESS/BIRTH CONTROL PILLS
A 25-year-old female suffered sudden deafness in the left ear after being placed on birth control pills. She had roaring in the ear for three days before the onset of deafness. She had no other medical problems. Five days after the pills were discontinued she reported return of her hearing.
In 1968 and 1971 other cases of sudden hearing loss were related to the contraceptive pill. (Journal of Laryngology and Otology 100:701-706, June 1976)






The Contraceptive Pill can cause Depression (due to Estrogens blocking the Serotonin manufacturing actions of Vitamin B6) - (Hyperhealth Medicinal Database)






BIRTH CONTROL PILLS/PREGNANCY OUTCOME
Women who have used oral contraceptives within three months of becoming pregnant are more likely to gain excessive weight during their pregnancy. They are more likely to have postmature infants, and have an increased incidence of neural tube defects. (European Journal of Obstetrics, Gynecology and Reproductive Biology 22:77- 83, 1986)